News Archive | South Bay Pain Doctors

south bay pain doctors | news

The Food and Drug Administration said Thursday it has asked Endo Pharmaceuticals to stop selling its reformulated, extended-release painkiller, Opana ER, after concluding the drug’s risks outweigh its benefits. It’s the first time the FDA has asked a drugmaker to remove an opioid painkiller from the market. The agency said it has seen a “significant […]

read more

One medicine can be the answer to all health problems. Truly Botox is an amazing medicine that has stunned people by providing numerous applications to treat many health problems. Allergan company is the owner of this medicine. For the last 30 years, this medicine stunned everyone living in the medical arena. With almost 800 patents […]

read more

Deaths linked to opioids are skyrocketing, and so is the number of Americans abusing the drugs, experts say. Two million Americans were dependent on prescription opioids in 2014, when the most recent data was available, federal statistics show. Overdoses linked to opioids killed more than 28,000 people nationwide two years ago, according to the Centers […]

read more

Dain Schroeder received his first opioid prescription for Crohn’s disease from a probably benevolent, but possibly misguided gastroenterologist. With that first order for hydrocodone, Mr. Schroeder started down a path of increasingly potent narcotics, emotional challenges, painful opioid withdrawals and stigma that came from within the health care system. After years of struggling with prescription […]

read more

The risk for developing depression may be up to twice as high in people receiving long-term opioids as it is in those taking these medications for shorter periods—over and above the depression inherently associated with having chronic pain, according to new study data (Ann Fam Med 2016;14:54-62). The researchers did not find a link between […]

read more

The FDA has announced another “bullet” in its fight against opioid-related misuse, abuse and death, issuing several new safety warnings, black box warnings and other labeling changes for all immediate-release (IR) opioids. The changes are very similar to those made in 2013 by the FDA for extended-release/long-acting (ER/LA) opioids, and as in that case, will […]

read more